Jason Fredette

Jason Fredette is an accomplished professional in investor relations and corporate communications, currently serving as Senior Vice President at Mersana Therapeutics since 2022. Previously, Jason held leadership roles at Axcella, Epizyme, Selecta Biosciences, and Chiasma, among others, demonstrating a strong track record in enhancing investor relations strategies. As President and Director of the NIRI Boston Chapter from 2013 to 2018, Jason directed the activities of a professional development organization with around 150 members. Earlier career experiences include establishing the investor relations function and leading communications at AMSC and guiding award-winning investor relations programs at Sharon Merrill Associates. Jason earned a Bachelor of Arts in Communications and a minor in Business Administration from Westfield State University.